Antigenicity and Immunogenicity of Recombinant Envelope Glycoproteins of SIVmac32H With Different in Vivo Passage Histories

Vaccine - Netherlands
doi 10.1016/0264-410x(95)00053-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immunogenicity and Antigenicity of a Recombinant Chimeric Protein Containing Epitopes of Poliovirus Type 1

Acta Virologica
MedicineVirologyInfectious Diseases
2016English

Safety and Immunogenicity of Hiv Recombinant Envelope Vaccines in Hiv-Infected Infants and Children. † 57

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Antigenicity and Immunogenicity of Plasmodium Vivax Merozoite Surface Protein-3

PLoS ONE
Multidisciplinary
2013English

Understanding the Immunogenicity and Antigenicity of Nanomaterials: Past, Present and Future

Toxicology and Applied Pharmacology
ToxicologyPharmacology
2016English

Determinants of Neutralization Resistance in the Envelope Glycoproteins of a Simian-Human Immunodeficiency Virus Passaged in Vivo

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1999English

Structure of Trimeric HIV-1 Envelope Glycoproteins

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Antigenicity and Immunogenicity of PvRALP1, a Novel Plasmodium Vivax Rhoptry Neck Protein

Malaria Journal
ParasitologyInfectious Diseases
2015English

Stability of the Glycoproteins From a Primary Human Pancreatic Carcinoma During Cell Culture and in Vivo Passage in Nude Mice

British Journal of Cancer
Cancer ResearchOncology
1983English

Protection of Macaques Against Simian AIDS by Immunization With a Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Simian Type D Retrovirus.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy